Susquehanna International Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,088,900
| Closed | -$381K | – | 10656 |
|
|
2016
Q3 | $381K | Sell |
1,088,900
-497,000
| -31% | -$174K | ﹤0.01% | 6542 |
|
|
2016
Q2 | $739K | Buy |
1,585,900
+1,169,800
| +281% | +$545K | ﹤0.01% | 5439 |
|
|
2016
Q1 | $566K | Buy |
416,100
+70,600
| +20% | +$96K | ﹤0.01% | 6185 |
|
|
2015
Q4 | $508K | Buy |
345,500
+8,500
| +3% | +$12.5K | ﹤0.01% | 6743 |
|
|
2015
Q3 | $532K | Sell |
337,000
-169,200
| -33% | -$267K | ﹤0.01% | 7005 |
|
|
2015
Q2 | $861K | Buy |
506,200
+103,400
| +26% | +$176K | ﹤0.01% | 6533 |
|
|
2015
Q1 | $560K | Buy |
402,800
+72,100
| +22% | +$100K | ﹤0.01% | 6889 |
|
|
2014
Q4 | $499K | Sell |
330,700
-343,000
| -51% | -$518K | ﹤0.01% | 7208 |
|
|
2014
Q3 | $1.39M | Sell |
673,700
-823,900
| -55% | -$1.7M | ﹤0.01% | 5282 |
|
|
2014
Q2 | $4.58M | Sell |
1,497,600
-701,200
| -32% | -$2.15M | ﹤0.01% | 3236 |
|
|
2014
Q1 | $5.5M | Buy |
2,198,800
+1,432,600
| +187% | +$3.58M | ﹤0.01% | 2754 |
|
|
2013
Q4 | $3.8M | Buy |
766,200
+567,400
| +285% | +$2.81M | ﹤0.01% | 3316 |
|
|
2013
Q3 | $452K | Buy |
198,800
+68,100
| +52% | +$155K | ﹤0.01% | 6582 |
|
|
2013
Q2 | $290K | Buy |
+130,700
| New | +$290K | ﹤0.01% | 6861 |
|
Susquehanna International Group's RXII Position: Q4 2016 in Review
Susquehanna International Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 535,907 shares — an estimated $188K sold.
Susquehanna International Group first reported a position in RXII in Q3 2013 and held it in 13 quarters. The position peaked at $1.78M in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Susquehanna International Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Susquehanna International Group sold 535,907 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $188K.
- Susquehanna International Group first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 13 quarters.
- Susquehanna International Group's GALENA BIOPHARMA INC COM position peaked at $1.78M in Q2 2014.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.